Jonas Salk :: essays research papers

Jonas Salk was natural in New York metropolis. His parents were Russian-Jewish immigrants who, although they themselves lacked formal education, were determined to behold their children succeed, and encouraged them to try out hard. Jonas Salk was the first member of his family to go to college. He entered the City College of New York intending to piece of work law, but soon became intrigued by medical exam science. bit attending medical school at New York University, Salk was invited to spend a year researching inininfluenzaenzaenza. The virus that causes flu had only recently been discovered and the green Salk was eager to gyp if the virus could be deprived of its ability to infect, plot of ground still endowment immunity to the illness. Salk succeeded in this attempt, which became the basis of his later pretend on infantile paralysis. by and by completing medical school and his internship, Salk returned to the study of influenza, the flu virus. World contend II had b egun, and public health experts feared a play back of the flu pestilent that had killed millions in the wake of the First World War. The nurture of vaccinums controlled the spread of flu after the war and the epidemic of 1919 did not recur. In 1947, Salk accepted an escort to the University Of Pittsburgh Medical School. While working there, with the National posterior for Infantile Paralysis, Salk maxim an opportunity to develop a vaccinum against acute anterior poliomyelitis, and abandoned himself to this work for the abutting eight historic period. In 1955 Salks years of research pay off. Human trials of the polio vaccine effectively protected the subject from the polio virus. When news of the discovery was made public on April 12, 1955, Salk was hailed as a miracle worker. He nurture endeared himself to the public by refusing to patent the vaccine. He had no desire to put on personally from the discovery, but merely wished to see the vaccine disseminated as astray as possible. Salks vaccine was composed of killed polio virus, which retained the ability to inoculate without running the risk of infecting the patient. A few years later, a vaccine made from unrecorded polio virus was developed, which could be administered orally, while Salks vaccine required injection. Further, there was some evidence that the killed vaccine failed to completely immunize the patient. In the U.S., public health authorities pick out to distribute the sleep together oral vaccine instead of Salks. Tragically, the preparation of live virus infected some patients with the disease, rather than immunizing them.Jonas Salk essays research papersJonas Salk was born in New York City. His parents were Russian-Jewish immigrants who, although they themselves lacked formal education, were determined to see their children succeed, and encouraged them to study hard. Jonas Salk was the first member of his family to go to college. He entered the City College of New York int ending to study law, but soon became intrigued by medical science. While attending medical school at New York University, Salk was invited to spend a year researching influenza. The virus that causes flu had only recently been discovered and the young Salk was eager to learn if the virus could be deprived of its ability to infect, while still giving immunity to the illness. Salk succeeded in this attempt, which became the basis of his later work on polio. After completing medical school and his internship, Salk returned to the study of influenza, the flu virus. World War II had begun, and public health experts feared a replay of the flu epidemic that had killed millions in the wake of the First World War. The development of vaccines controlled the spread of flu after the war and the epidemic of 1919 did not recur. In 1947, Salk accepted an appointment to the University Of Pittsburgh Medical School. While working there, with the National Foundation for Infantile Paralysis, Salk saw a n opportunity to develop a vaccine against polio, and devoted himself to this work for the next eight years. In 1955 Salks years of research paid off. Human trials of the polio vaccine effectively protected the subject from the polio virus. When news of the discovery was made public on April 12, 1955, Salk was hailed as a miracle worker. He further endeared himself to the public by refusing to patent the vaccine. He had no desire to profit personally from the discovery, but merely wished to see the vaccine disseminated as widely as possible. Salks vaccine was composed of killed polio virus, which retained the ability to immunize without running the risk of infecting the patient. A few years later, a vaccine made from live polio virus was developed, which could be administered orally, while Salks vaccine required injection. Further, there was some evidence that the killed vaccine failed to completely immunize the patient. In the U.S., public health authorities elected to distribute t he live oral vaccine instead of Salks. Tragically, the preparation of live virus infected some patients with the disease, rather than immunizing them.